Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anterior Suprascapular Nerve Block is as Effective as Interscalene Nerve Block and Causes Less Diapragm Paralysis in Arthroscopic Shoulder Surgery

NCT04626869 is registered in ClinicalTrials.gov with Alper Tunga Dogan as lead sponsor.

NCT NCT04626869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anterior Suprascapular Nerve Block is as Effective as Interscalene Nerve Block and Causes Less Diapragm Paralysis in Arthroscopic Shoulder Surgery
Lead sponsor
Alper Tunga Dogan
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2020
Completion date
April 1, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, arthroscopic shoulder surgery, anterior suprascapular nerve block, diaphragm paralysis due to local anesthesia